1![ProteinSafeTM Protease Inhibitor Cocktail (100×) ProteinSafeTM Protease Inhibitor Cocktail (100×)](https://www.pdfsearch.io/img/bef172b2f86b330c112985c105756301.jpg) | Add to Reading ListSource URL: www.transgen.com.cn- Date: 2017-10-09 00:36:23
|
---|
2![Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric](https://www.pdfsearch.io/img/f317dd90216dab5405c34c20cb84d068.jpg) | Add to Reading ListSource URL: www.cellcentric.comLanguage: English - Date: 2018-04-17 06:58:57
|
---|
3![Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro](https://www.pdfsearch.io/img/866ddb15ec59d2eedee67af40975650b.jpg) | Add to Reading ListSource URL: www.eumbrella.orgLanguage: English - Date: 2016-02-26 09:44:29
|
---|
4![Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th](https://www.pdfsearch.io/img/82997e89fc85299534b4d6b5ce91f517.jpg) | Add to Reading ListSource URL: apac-asia.comLanguage: English - Date: 2017-05-01 03:53:28
|
---|
5![Aging Cell, pp872–884 Doi: acelLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an a-glucosidase inhibitor or a Aging Cell, pp872–884 Doi: acelLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an a-glucosidase inhibitor or a](https://www.pdfsearch.io/img/fdcaa7182ec3885ddb933966d5ee9873.jpg) | Add to Reading ListSource URL: pcwww.liv.ac.ukLanguage: English - Date: 2016-09-08 18:38:10
|
---|
6![FOR IMMEDIATE RELEASE Tokyo, January 12, 2018 Top-line Results of the Topical JTE-052 JAK Inhibitor Phase 3 Clinical Study (Comparative Study) in Japan FOR IMMEDIATE RELEASE Tokyo, January 12, 2018 Top-line Results of the Topical JTE-052 JAK Inhibitor Phase 3 Clinical Study (Comparative Study) in Japan](https://www.pdfsearch.io/img/60ad10fe77257e4f205c83b2c568d3db.jpg) | Add to Reading ListSource URL: www.torii.co.jpLanguage: English - Date: 2018-01-11 20:24:46
|
---|
7![Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Alliso Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Alliso](https://www.pdfsearch.io/img/b9e795e5fd8be86ca7fa0b39dbba34d7.jpg) | Add to Reading ListSource URL: engelmanlab.med.harvard.eduLanguage: English - Date: 2013-05-21 15:55:24
|
---|
8![Journal of Cellular Biochemistry 103:972–Raf Kinase Inhibitor Protein Positively Regulates Cell–Substratum Adhesion While Negatively Regulating Cell–Cell Adhesion Kevin T. Mc Henry,1 Roberto Montesano,2 Journal of Cellular Biochemistry 103:972–Raf Kinase Inhibitor Protein Positively Regulates Cell–Substratum Adhesion While Negatively Regulating Cell–Cell Adhesion Kevin T. Mc Henry,1 Roberto Montesano,2](https://www.pdfsearch.io/img/92892d3f2eb2973d9e6ac92423039060.jpg) | Add to Reading ListSource URL: biochemweb.netLanguage: English - Date: 2015-09-29 23:11:38
|
---|
9![Dries 1 Annika Dries Human Biology 158G Final Project 6 December 2013 The PARP inhibitor: the promises and challenges of targeted breast cancer therapy Dries 1 Annika Dries Human Biology 158G Final Project 6 December 2013 The PARP inhibitor: the promises and challenges of targeted breast cancer therapy](https://www.pdfsearch.io/img/98ee65c40579aee7f36a2b09e0740569.jpg) | Add to Reading ListSource URL: biochem158.stanford.eduLanguage: English - Date: 2013-12-15 18:24:45
|
---|
10![A narrow spectrum kinase inhibitor, RV1729, induces bronchodilation of human small airways and rescues agonist-induced desensitization of the β2 adrenoreceptor (β2AR) 1 Koziol-White , 1 A narrow spectrum kinase inhibitor, RV1729, induces bronchodilation of human small airways and rescues agonist-induced desensitization of the β2 adrenoreceptor (β2AR) 1 Koziol-White , 1](https://www.pdfsearch.io/img/c1991262bcb0be4e47485e274173bd79.jpg) | Add to Reading ListSource URL: ritms.rutgers.edu- Date: 2018-01-11 17:19:27
|
---|